• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Porcine Sertoli cells aseptically prepared for intracerebral co-implantation with fetal neural tissue
Date Designated: 06/24/1997
Orphan Designation: Treatment of Hoehn and Yahr stage four and five Parkinson's disease.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Titan Pharmaceuticals, Inc.
Post Office Plaza
50 Division Street, Suite 503
Somerville, New Jersey 08876
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-